Annual Retained Earnings
-$1.45 B
-$321.55 M-28.57%
December 31, 2024
Summary
- As of February 26, 2025, TVTX annual retained earnings is -$1.45 billion, with the most recent change of -$321.55 million (-28.57%) on December 31, 2024.
- During the last 3 years, TVTX annual retained earnings has fallen by -$681.20 million (-88.93%).
- TVTX annual retained earnings is now -1192947.82% below its all-time high of -$121.30 thousand, reached on February 28, 2011.
Performance
TVTX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$1.45 B
-$60.26 M-4.35%
December 1, 2024
Summary
- As of February 26, 2025, TVTX quarterly retained earnings is -$1.45 billion, with the most recent change of -$60.26 million (-4.35%) on December 1, 2024.
- Over the past year, TVTX quarterly retained earnings has dropped by -$321.55 million (-28.57%).
- TVTX quarterly retained earnings is now -1192947.82% below its all-time high of -$121.30 thousand, reached on February 28, 2011.
Performance
TVTX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
TVTX Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -28.6% | -28.6% |
| 3 y3 years | -88.9% | -28.6% |
| 5 y5 years | -247.5% | -28.6% |
TVTX Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -88.9% | at low | -88.9% | at low |
| 5 y | 5-year | -247.5% | at low | -248.2% | at low |
| alltime | all time | <-9999.0% | at low | <-9999.0% | at low |
Travere Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | -$1.45 B(+28.6%) | - |
| Dec 2024 | - | -$1.45 B(+4.3%) |
| Sep 2024 | - | -$1.39 B(+4.1%) |
| Jun 2024 | - | -$1.33 B(+5.6%) |
| Mar 2024 | - | -$1.26 B(+12.1%) |
| Dec 2023 | -$1.13 B(+11.0%) | -$1.13 B(+8.7%) |
| Sep 2023 | - | -$1.04 B(-12.7%) |
| Jun 2023 | - | -$1.19 B(+7.8%) |
| Mar 2023 | - | -$1.10 B(+8.5%) |
| Dec 2022 | -$1.01 B(+32.4%) | -$1.01 B(+6.9%) |
| Sep 2022 | - | -$948.40 M(+7.9%) |
| Jun 2022 | - | -$878.74 M(+8.3%) |
| Mar 2022 | - | -$811.71 M(+6.0%) |
| Dec 2021 | -$765.97 M(+30.7%) | -$765.97 M(+7.2%) |
| Sep 2021 | - | -$714.39 M(+5.3%) |
| Jun 2021 | - | -$678.75 M(+6.1%) |
| Mar 2021 | - | -$639.74 M(+9.2%) |
| Dec 2020 | -$585.88 M(+40.7%) | -$585.88 M(+26.2%) |
| Sep 2020 | - | -$464.25 M(+5.1%) |
| Jun 2020 | - | -$441.70 M(+6.3%) |
| Mar 2020 | - | -$415.64 M(-0.2%) |
| Dec 2019 | -$416.44 M(+54.2%) | -$416.44 M(+7.8%) |
| Sep 2019 | - | -$386.19 M(+10.4%) |
| Jun 2019 | - | -$349.69 M(+12.4%) |
| Mar 2019 | - | -$310.99 M(+15.2%) |
| Dec 2018 | -$270.02 M(+52.0%) | -$270.02 M(+2.8%) |
| Sep 2018 | - | -$262.56 M(+26.2%) |
| Jun 2018 | - | -$208.05 M(+12.0%) |
| Mar 2018 | - | -$185.72 M(+4.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2017 | -$177.66 M(+57.1%) | -$177.66 M(+11.0%) |
| Sep 2017 | - | -$160.04 M(+12.5%) |
| Jun 2017 | - | -$142.24 M(+10.3%) |
| Mar 2017 | - | -$129.01 M(+14.1%) |
| Dec 2016 | -$113.06 M(+73.5%) | -$113.06 M(+8.2%) |
| Sep 2016 | - | -$104.45 M(+55.1%) |
| Jun 2016 | - | -$67.34 M(+24.8%) |
| Mar 2016 | - | -$53.94 M(-17.2%) |
| Dec 2015 | -$65.15 M(-63.6%) | -$65.15 M(+3.9%) |
| Sep 2015 | - | -$62.68 M(-62.7%) |
| Jun 2015 | - | -$168.26 M(+17.9%) |
| Mar 2015 | - | -$142.73 M(-20.3%) |
| Dec 2014 | -$179.18 M(+162.6%) | -$179.18 M(+20.1%) |
| Sep 2014 | - | -$149.13 M(+15.1%) |
| Jun 2014 | - | -$129.58 M(-6.1%) |
| Mar 2014 | - | -$138.06 M(+102.3%) |
| Dec 2013 | -$68.24 M(+103.0%) | -$68.24 M(+25.7%) |
| Sep 2013 | - | -$54.30 M(+25.1%) |
| Jun 2013 | - | -$43.40 M(+13.2%) |
| Mar 2013 | - | -$38.35 M(>+9900.0%) |
| Dec 2012 | -$33.61 M(>+9900.0%) | - |
| Nov 2012 | - | -$146.80 K(+2.6%) |
| Aug 2012 | - | -$143.10 K(+2.5%) |
| May 2012 | - | -$139.60 K(+2.6%) |
| Feb 2012 | - | -$136.10 K(+3.3%) |
| Feb 2012 | -$136.10 K(+12.2%) | - |
| Nov 2011 | - | -$131.80 K(+2.7%) |
| Aug 2011 | - | -$128.30 K(+5.8%) |
| Feb 2011 | -$121.30 K | -$121.30 K |
FAQ
- What is Travere Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Travere Therapeutics?
- What is Travere Therapeutics annual retained earnings year-on-year change?
- What is Travere Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Travere Therapeutics?
- What is Travere Therapeutics quarterly retained earnings year-on-year change?
What is Travere Therapeutics annual retained earnings?
The current annual retained earnings of TVTX is -$1.45 B
What is the all time high annual retained earnings for Travere Therapeutics?
Travere Therapeutics all-time high annual retained earnings is -$121.30 K
What is Travere Therapeutics annual retained earnings year-on-year change?
Over the past year, TVTX annual retained earnings has changed by -$321.55 M (-28.57%)
What is Travere Therapeutics quarterly retained earnings?
The current quarterly retained earnings of TVTX is -$1.45 B
What is the all time high quarterly retained earnings for Travere Therapeutics?
Travere Therapeutics all-time high quarterly retained earnings is -$121.30 K
What is Travere Therapeutics quarterly retained earnings year-on-year change?
Over the past year, TVTX quarterly retained earnings has changed by -$321.55 M (-28.57%)